We're excited to introduce the accredited BackTable Tumor Board course series! Dive deep into contemporary hepatocellular carcinoma (HCC) care with collaborative insights from medical oncologists, interventional radiologists, hepatobiliary surgeons, hepatologists, and other healthcare specialties. Earn CME/CE for completing learning activities within these courses.
This course explores a multidisciplinary approach to HCC care, covering patient flow in combined clinics, the role of combination therapies and clinical trials for advanced HCC, and strategies for managing complex cases.
This course covers Y-90 dosimetry, curative intent therapies for HCC, and practical guidance for building a successful interventional oncology practice, offering clinicians the tools to optimize treatment strategies and patient outcomes.
This course highlights collaborative approaches to HCC management, covering surgical strategies including downstaging, transplant perspectives from surgeons and hepatologists, and multidisciplinary tumor board insights on managing disease progression
